Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 December 2023 | Story André Damons | Photo Charl Devenish
Dr Shezree Tiel
Top student: Dr Shezree Tiel graduated top of her class and summa cum laude during the Faculty of Health Sciences graduation ceremony on Friday.

As she achieved the goals she had set for herself, Dr Shezree Tiel, one of the latest graduates from the University of the Free State (UFS) Faculty of Health Sciences (FoHS), developed the courage to not only define her goals, but aim for even more. This is the reason she graduated not only summa cum laude, but as the top student in her year group.

Dr Tiel was one of 459 students who graduated on Friday (8 December 2023) during the FoHS’s December graduation ceremony. She graduated with a MBChB degree and is one of eight students to do so summa cum laude. During her five years of studies to become a medical doctor, she was the top student in each of her year groups.  

“I feel very excited and still in disbelief, because it has been my dream since first year to graduate cum laude, but there were moments I felt I may have to accept that it may not be possible. So, I am very delighted that despite all the challenges I faced, my dream was realised,” she said.

According to her, she decided to study at UFS as it is the only university in South Africa that offered a five-year medical degree.

Building healthier and happier communities

Talking about how she achieved this, Dr Tiel, who will be doing her community service year in her home province of Mpumalanga, said what was consistent throughout her years of study, was the need to avoid a uniform approach to studying. Instead, she continued, she embraced different ways to learn.

Said Dr Tiel: “I embraced different ways to acquire knowledge and used these to identify a method of study that would be best suited for each module, chapter and sometimes each day. Everyday courage, resilience, patience, and perseverance played a vital role in accomplishing all my achievements. In spite of all of this, I will always attribute my achievements to my trust in Christ.”

Her desire to make the best possible use of every opportunity she gets to gain knowledge and the hope to use that knowledge to be useful to people and communities, motivated her on her journey to become a doctor. She decided to study medicine because she aspired to work with people in the pursuit of building healthier and happier communities. She believed that medicine would provide a great foundation and platform to accomplish this.

Though she is yet to decide in which field she would like to specialise one day, she believes it would be in internal medicine because it has always been one of her favourite rotations. “I do hope whichever one I go into will provide me with an opportunity to teach because that is one of the things I delight in.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept